Sequences

Sample result

SIINFEKL, an exact peptide

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

2,028 publications in 1,357 families match these filters.

  1. US 9439859-B22016-09-13

    Adjuvant incorporation in immunoanotherapeutics

    Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc. and Presidents and Fellows of Harvard College

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  2. CD27 AGONISTS

    CELLDEX THERAPEUTICS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  3. MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE

    THE US SECRETARY DEPT OF HEALTH AND HUMAN SERVICES

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  4. US 9446115-B22016-09-20

    Methods of stimulating immunity employing dengue viral antigens

    VaxInnate Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 765 to 772. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   765 SIINFEKL 772
    

    8 of 8 identical, no gaps.

  5. CELL PENETRATING PEPTIDES AND COMPLEXES COMPRISING THE SAME

    AMAL THERAPEUTICS SA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 35 to 42. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   35 SIINFEKL 42
    

    8 of 8 identical, no gaps.

  6. A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF GLIOBLASTOMA

    AMAL THERAPEUTICS SA

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 121 to 128. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   121 SIINFEKL 128
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  7. A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST

    AMAL THERAPEUTICS SA

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 121 to 128. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   121 SIINFEKL 128
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  8. COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR USE IN MEDICINE

    AMAL THERAPEUTICS SA

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 8, hit 121 to 128. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   121 SIINFEKL 128
    

    8 of 8 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  9. A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF COLORECTAL CANCER

    AMAL THERAPEUTICS SA

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 121 to 128. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   121 SIINFEKL 128
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  10. JP 2016529271-A2016-09-23

    Compound and method

    PCI Biotech AS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  11. JP 2016530239-A2016-09-29

    COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MOLECULES DERIVED FROM MICROBIOTA FOR TREATMENT OF DISEASE

    PureTech Ventures LLC,RIKEN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  12. POROUS SILICON MICROPARTICLE-BASED CANCER VACCINES AND METHODS FOR POTENTIATING ANTI-TUMORAL IMMUNITY

    THE METHODIST HOSPITAL

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  13. JP 2016531927-A2016-10-13

    PAPAYA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES IN CANCER THERAPY

    FOLIA BIOTECH INC,Alan LAMARRE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  14. IMMUNOGENIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

    ADURO BIOTECH INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 476 to 483. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   476 SIINFEKL 483
    

    8 of 8 identical, no gaps.

  15. JP 2016534978-A2016-11-10

    COMPOSITIONS AND FORMULATIONS FOR MAINTAINING AND INCREASING MUSCLE MASS, STRENGTH AND PERFORMANCE, AND METHODS OF PRODUCTION AND USE THEREOF

    PRONUTRIA INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 61/882129.

  16. US 9493545-B22016-11-15

    Albumin variants and conjugates

    Albumedix A/S

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  17. JP 2016193865-A2016-11-17

    Method for prediction of microglial phagocytic activity and composition for stimulation of phagositic actibity of microglia

    Kirin Company Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  18. US 9505824-B22016-11-29

    Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation

    Kanagawa Prefectural Hospital Organization

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  19. WO 2016190395-A2016-12-01

    Composition containing of peptide for inflammatory supression

    Kirin Company Limited

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  20. US 9511137-B22016-12-06

    Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof

    CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS and INIS BIOTECH LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  21. EP 3101134-A12016-12-07

    THERAPEUTIC VACCINE FOR TREATING OR PREVENTING MERKEL CELL POLYOMA VIRUS-ASSOCIATED TUMORS

    APCURE SAS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  22. US 9522962-B22016-12-20

    Peptides, conjugates and method for increasing immunogenicity of a vaccine

    Academisch Ziekenhuis Leiden h.o.d.n. LUMC and Stichting voor de Technische Wetenschappen

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  23. US 9534221-B22017-01-03

    Targeting the steroidogenic pathway for treating and/or preventing allergic diseases

    National Jewish Health

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  24. MEANS AND METHODS FOR TREATING CMV

    Pfizer Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  25. US 9539313-B22017-01-10

    Recombinant bacterium and uses thereof

    National Research Council of Canada

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 395 to 402. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   395 SIINFEKL 402
    

    8 of 8 identical, no gaps.

  26. US 9539320-B22017-01-10

    Vaccine immunotherapy

    IRX Therapeutics, Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  27. EP 3118326-A22017-01-18

    MOLECULAR MARKER FOR CANCER STEM CELL

    SAPPORO MEDICAL UNIV

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  28. JP 2017018129-A2017-01-26

    INDIVIDUALIZED VACCINES FOR CANCER

    BIONTECH AG, TRON -TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  29. US 9554995-B22017-01-31

    Nanoemulsions

    The University of Queensland

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  30. US 9555074-B22017-01-31

    Annexin II compositions

    Regents of the University of Minnesota

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 10 to 17. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   10 SIINFEKL 17
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  31. Modified adenoviruses for cancer vaccines development

    HELSINGIN YLIOPISTO

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  32. US 9561275-B22017-02-07

    Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

    The Johns Hopkins University

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  33. EP 3125927-A12017-02-08

    METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

    RUBIUS THERAPEUTICS INC

    Query Match 100.0%Identity 100.0%Family of 6

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 6

    Grouped by a shared priority claim, US 61/973763.

  34. WO 2017022793-A2017-02-09

    Composition for promoting immune induction and Vaccine pharmaceutical composition

    NITTO DENKO CORPORATION

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. US 9566304-B22017-02-14

    Pharmaceutical composition for preventing or treating cancers comprising dendritic cells with Dab2 gene silenced

    Research & Business Foundation Sungkyunkwan University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  36. TRANSINFECTED LYMPHOCYTES FOR ANTI-TUMOR THERAPY

    CONSEJO SUPERIOR DE INVESTIG CIENTIFICAS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  37. US 9574000-B22017-02-21

    Anti-human B7-H4 antibodies and their uses

    MedImmune, LLC and The Johns Hopkins University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  38. QUANTITATIVE PEPTIDE OR PROTEIN ASSAY

    Pierce Biotechnology, Inc

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  39. JP 2017507180-A2017-03-16

    Glycotargeting Therapeutics

    ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE,ANOKION SA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   257 SIINFEKL 264
    

    8 of 8 identical, no gaps.

  40. USE OF PERFORIN POSITIVE IMMATURE DENDRITIC CELLS IN DISEASE TREATMENT

    YEDA RES & DEV

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  41. US 9598474-B22017-03-21

    Nutritive fragments, proteins and methods

    Axcella Health, Inc.

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  42. JP 2017507950-A2017-03-23

    ADOPTIVE CELLULAR THERAPY USING AN ANTAGONIST OF RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR GAMMA & RELATED THERAPEUTIC METHODS

    LYCERA CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  43. US 9603923-B22017-03-28

    Universal carrier for targeting molecules to GB3 receptor expressing cells

    INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE and UNIVERSITE PIERRE ET MARIE CURIE (PARIS VI)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  44. US 9605040-B22017-03-28

    Nutritive proteins and methods

    Axcella Health Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  45. COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE VACCINE DELIVERY

    MASSACHUSETTS INST TECHNOLOGY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  46. US 9611298-B22017-04-04

    Charged nutritive proteins and methods

    Axcella Health Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  47. JP 2017509642-A2017-04-06

    A medicament for use in a method of inducing or extending a cellular cytotoxic immune response

    Bundesrepublik Deutschland letztvertreten durch das Robert Koch-Institut vertreten durch seinen Prasidenten

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 25 to 32. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   25 SIINFEKL 32
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  48. WO 2017057540-A2017-04-06

    Nucleic derivatives having immunostimulatory activity

    Shionogi and Co Ltd

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  49. NUCLEIC ACIDS

    Scancell Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 75 to 82. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   75 SIINFEKL 82
    

    8 of 8 identical, no gaps.

  50. JP 2017511478-A2017-04-20

    Peptides, Reagents and Methods for Detecting Food Allergy

    Genisphere LLC,ICAHN School of Medicine at Mount Sinai,Robert C Getts, James Kadushin,Hugh A Sampson,Luda Bardina,Galina Grishina,Gustavo Gimenez, Jing Lin

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.